We conducted a retrospective study investigating the expression of the CD47 molecule in both tumor cells and tumor-infiltrating immune cells (TIIC) in the center and periphery of primary tumors from 43 patients with SGC with 5 different histological subtypes. The gene discussed is CD47; the disease is neoplasm.